Question 1

What is the catalog number for Mouse Monoclonal VEGF R2/KDR/Flk-1 Antibody (1B6) [DyLight 594]?

Accepted Answer

The catalog number for Mouse Monoclonal VEGF R2/KDR/Flk-1 Antibody (1B6) [DyLight 594] is NBP2-36428DL594.

Question 2

What sizes are available for Mouse Monoclonal VEGF R2/KDR/Flk-1 Antibody (1B6) [DyLight 594]?

Accepted Answer

Mouse Monoclonal VEGF R2/KDR/Flk-1 Antibody (1B6) [DyLight 594] is available in the following size(s): 0.1 mL.

Question 3

Is Mouse Monoclonal VEGF R2/KDR/Flk-1 Antibody (1B6) [DyLight 594] in stock?

Accepted Answer

Mouse Monoclonal VEGF R2/KDR/Flk-1 Antibody (1B6) [DyLight 594] is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Question 5

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

Question 6

How should this product be stored?

Accepted Answer

Storage conditions depend on the specific reagent and are listed on the product datasheet, with most antibodies and proteins requiring -20°C unless stated otherwise. It is your responsibility to store the product correctly immediately upon receipt; damage from improper storage after delivery is not eligible for replacement.

Mouse Monoclonal VEGF R2/KDR/Flk-1 Antibody (1B6) [DyLight 594]

Product Specifications

CAS Number

Frequently Asked Questions

Explore Other Products

Anti-TCF4 Antibody Picoband®

Anti-Cytochrome P450 17A1/Cyp17a1 Antibody Picoband® (FITC Conjugate)

IL3RA / CD123 (Acute Myeloid Leukemia Marker) (IL3RA/2065), CF488A conjugate, 0.1mg/mL

Anti-TIE2/TEK Antibody Picoband®, Dylight550 Conjugate

Rat IL-12(p70) ELISA Kit PicoKine®, Carrier-free

ZIP Kinase Recombinant Rabbit Monoclonal Antibody [PSH02-18]